139579-00-3

Basic information

• Product Name: (2S,4R)-2-{(S)-2-[(2S,6R)-6-(4-Benzoylamino-2-oxo-2H-pyrimidin-1-yl)-4-trityl-morpholin-2-ylmethoxycarbonyl]-pyrrolidine-1-carbonyl}-4-(4-nitro-phenoxycarbonyloxy)-pyrrolidine-1-carboxylic acid 2-benzenesulfonyl-ethyl ester
• CAS NO: 139579-00-3
• Molecular Weight: 1160.23
• Mol File: 139579-00-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,4R)-2-{(S)-2-[(2S,6R)-6-(4-Benzoylamino-2-oxo-2H-pyrimidin-1-yl)-4-trityl-morpholin-2-ylmethoxycarbonyl]-pyrrolidine-1-carbonyl}-4-(4-nitro-phenoxycarbonyloxy)-pyrrolidine-1-carboxylic acid 2-benzenesulfonyl-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,4R)-2-{(S)-2-[(2S,6R)-6-(4-Benzoylamino-2-oxo-2H-pyrimidin-1-yl)-4-trityl-morpholin-2-ylmethoxycarbonyl]-pyrrolidine-1-carbonyl}-4-(4-nitro-phenoxycarbonyloxy)-pyrrolidine-1-carboxylic acid 2-benzenesulfonyl-ethyl ester(139579-00-3)
• EPA Substance Registry System: (2S,4R)-2-{(S)-2-[(2S,6R)-6-(4-Benzoylamino-2-oxo-2H-pyrimidin-1-yl)-4-trityl-morpholin-2-ylmethoxycarbonyl]-pyrrolidine-1-carbonyl}-4-(4-nitro-phenoxycarbonyloxy)-pyrrolidine-1-carboxylic acid 2-benzenesulfonyl-ethyl ester(139579-00-3)

Safety Data

• Hazardous Substances Data: 139579-00-3(Hazardous Substances Data)

Upstream product

• 139578-71-5 (S)-Pyrrolidine-1,2-dicarboxylic acid 2-[(2S,6R)-6-(4-benzoylamino-2-oxo-2H-pyrimidin-1-yl)-4-trityl-morpholin-2-ylmethyl] ester 1-(9H-fluoren-9-ylmethyl) ester 
• 125515-31-3 N-{1-[(2R,6)-6-(hydroxymethyl)-4-tritylmorpholin-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}benzamide 
• 71989-31-6 Fmoc-Pro-OH 
• 5070-13-3 bis-(p-nitrophenyl) carbonate 
• 139578-73-7 (2S,4R)-2-{(S)-2-[(2S,6R)-6-(4-Benzoylamino-2-oxo-2H-pyrimidin-1-yl)-4-trityl-morpholin-2-ylmethoxycarbonyl]-pyrrolidine-1-carbonyl}-4-hydroxy-pyrrolidine-1-carboxylic acid 2-benzenesulfonyl-ethyl ester 

Relevant articles and documents

SOLID PHASE SYNTHESIS OF NEUTRAL OLIGONUCLEOTIDE ANALOGUES

The combination of an anchor for solid phase synthesis which allows release of fully protected oligonucleotide analogues from the solid support and base protective groups which provide water solubility has been shown to facilitate isolation, purification, and characterization of neutral oligonucleotide analogues derived from morpholine nucleosides.